A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Evolent Health, Inc. stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 137,100 shares of EVH stock, worth $1.69 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
137,100
Previous 131,800 4.02%
Holding current value
$1.69 Million
Previous $2.52 Million 53.85%
% of portfolio
0.04%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.41 - $32.97 $97,573 - $174,741
5,300 Added 4.02%
137,100 $3.88 Million
Q2 2024

Aug 13, 2024

BUY
$19.12 - $31.93 $665,376 - $1.11 Million
34,800 Added 35.88%
131,800 $2.52 Million
Q3 2023

Nov 08, 2023

BUY
$25.0 - $31.4 $12,500 - $15,700
500 Added 0.52%
97,000 $2.64 Million
Q3 2022

Nov 10, 2022

SELL
$29.37 - $39.74 $99,858 - $135,116
-3,400 Reduced 3.4%
96,500 $3.47 Million
Q2 2022

Aug 12, 2022

SELL
$25.9 - $32.26 $119,140 - $148,396
-4,600 Reduced 4.4%
99,900 $3.07 Million
Q1 2022

May 13, 2022

SELL
$22.14 - $32.3 $44,280 - $64,599
-2,000 Reduced 1.88%
104,500 $3.38 Million
Q3 2021

Nov 12, 2021

SELL
$20.93 - $31.0 $345,345 - $511,500
-16,500 Reduced 13.41%
106,500 $3.3 Million
Q1 2021

May 14, 2021

SELL
$16.19 - $21.22 $259,040 - $339,520
-16,000 Reduced 11.51%
123,000 $2.49 Million
Q4 2020

Feb 05, 2021

SELL
$9.92 - $16.43 $158,720 - $262,880
-16,000 Reduced 10.32%
139,000 $2.23 Million
Q3 2020

Nov 06, 2020

SELL
$7.4 - $14.33 $29,600 - $57,320
-4,000 Reduced 2.52%
155,000 $1.92 Million
Q2 2020

Aug 13, 2020

SELL
$4.8 - $9.42 $739,214 - $1.45 Million
-154,003 Reduced 49.2%
159,000 $1.13 Million
Q4 2019

Feb 14, 2020

BUY
$6.49 - $10.68 $227,150 - $373,800
35,000 Added 12.59%
313,003 $2.83 Million
Q3 2019

Nov 01, 2019

BUY
$5.82 - $8.31 $197,880 - $282,540
34,000 Added 13.93%
278,003 $2 Million
Q2 2019

Aug 02, 2019

BUY
$7.71 - $14.54 $166,536 - $314,064
21,600 Added 9.71%
244,003 $1.94 Million
Q1 2019

May 02, 2019

BUY
$12.17 - $20.92 $480,715 - $826,340
39,500 Added 21.6%
222,403 $2.8 Million
Q4 2018

Jan 30, 2019

BUY
$17.75 - $27.2 $186,375 - $285,600
10,500 Added 6.09%
182,903 $3.65 Million
Q3 2018

Nov 02, 2018

SELL
$20.1 - $28.75 $194,970 - $278,875
-9,700 Reduced 5.33%
172,403 $4.9 Million
Q2 2018

Aug 10, 2018

BUY
$13.8 - $23.95 $1,380 - $2,395
100 Added 0.05%
182,103 $3.83 Million
Q1 2018

May 09, 2018

BUY
$12.8 - $16.5 $204,800 - $264,000
16,000 Added 9.64%
182,003 $2.59 Million
Q4 2017

Feb 02, 2018

BUY
$10.5 - $18.7 $955,500 - $1.7 Million
91,000 Added 121.33%
166,003 $2.04 Million
Q3 2017

Nov 01, 2017

BUY
$15.65 - $24.75 $1.17 Million - $1.86 Million
75,003
75,003 $1.34 Million

Others Institutions Holding EVH

About Evolent Health, Inc.


  • Ticker EVH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 97,063,696
  • Market Cap $1.2B
  • Description
  • Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...
More about EVH
Track Mario Gabelli's Portfolio

Track Mario Gabelli Portfolio

Follow Mario Gabelli (Gamco Investors, Inc. Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.